Caregivers were positive about the system's responsiveness with its “automatic basal rate adjustment for high and low glucose levels” and “automatic shutdown in case of hypoglycemia.” They also felt reassured by the ability of the closed‐loop system to “give the exact amount of insulin which is required.” These features reduced the burden of disease management as caregivers spent less time performing diabetes‐related activities (“less ‘visual inspection’ on pump + less BG measurements”). The gene discussed is INS; the disease is diabetes mellitus.